VivoSim Labs, Inc. Share Price

VivoSim Labs, Inc. Share Price

NASDAQ: VIVS
$0.16
+$0.01 (9.22%) Last updated on 29 Oct, 2026 | 21:04 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

VivoSim Labs, Inc. Stock Performance

Open
$0.15
Prev. Close
$0.14
Circuit Range
N/A
Day Range
$0.15 - $0.16
Year Range
$0.14 - $3.40
Volume
1,550
Average Traded
$0.16

VivoSim Labs, Inc. Share Price Today

As of 29 October 2026, VivoSim Labs, Inc.'s share price is $0.16. The stock opened at $0.15, compared to its previous close of $0.14. During today's trading session, VivoSim Labs, Inc.'s share price traded between $0.15 and $0.16, with an average price of $0.16. Over the past 52 weeks, the stock has recorded a high of $3.40 and a low of $0.14. In terms of performance, VivoSim Labs, Inc.'s share price has declined by 89.06% over the last six months and is down 94.19% on a year-on-year basis.

VivoSim Labs, Inc. Share Price Chart

Line chart of the VivoSim Labs, Inc. price trend over the selected period. The price rose overall, ranging from 0.15 to 0.16, ending at 0.16.
$0.15$0.16
L
Show Current Price
H

VivoSim Labs, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.92
Revenue (TTM)
$130.00M
Return On Equity (TTM)
525.92%
Profit Margin
-10646.15%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
47.45%

VivoSim Labs, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.03$0.03$0.04$0.02
Net Profit-$2.55-$2.69-$5.76-$1.34
Net Profit Margin-8500.00%-8966.67%-14400.00%-6700.00%
Income ChangeN/A-5.49%-114.13%76.74%

VivoSim Labs, Inc. Annual Profit & Loss

All figures in USD

Particulars2026
Revenue$0.13
Net Profit-$13.84
Net Profit Margin-10646.15%
Income ChangeN/A

About VivoSim Labs, Inc.

VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.

VivoSim Labs, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$0.21
$0.15
-27.57%
Sep 2026
$0.28
$0.21
-27.46%
Aug 2026
$0.34
$0.29
-14.24%
Jul 2026
$1.03
$0.34
-67.85%
Jun 2026
$1.28
$1.07
-17.05%
May 2026
$1.39
$1.29
-10.42%
Apr 2026
$1.26
$1.44
+2.86%
Mar 2026
$2.07
$1.40
-35.48%
Feb 2026
$2.74
$2.17
-27.42%
Jan 2026
$2.01
$2.99
+63.39%
Dec 2025
$2.11
$1.83
-18.30%
Nov 2025
$2.58
$2.24
-17.34%

VIVS Share Price FAQs